Toxoplasmosis Research Center, Communicable Diseases Institute, Iranian National Registry Center for Lophomoniasis (INRCL), Mazandaran University of Medical Sciences, Farah-Abad Road, P.O Box: 48471- 91971, Sari, Iran.
Pulmonary and Critical Care Division, Imam Khomeini Hospital, Mazandaran University of Medical Sciences, P.O Box: 48166-33131, Sari, Iran.
Acta Parasitol. 2021 Dec;66(4):1510-1516. doi: 10.1007/s11686-021-00422-3. Epub 2021 Jun 11.
In the last decade, several cases of bronchopulmonary lophomoniasis (BPL) have been recorded. Little information is available about epidemiological aspects on Lophomonas infection among BPL patients. The present study was aimed to investigate the prevalence of Lophomonas spp. infection in patients who were referred to the Iranian National Registry Center for Lophomoniasis (INRCL), using morphological and molecular tests.
We examined patients enrolled in the INRCL from 2017 to 2019 at the Mazandaran University of Medical Sciences, northern Iran. All bronchoalveolar lavage fluid (BALF) and two nasal discharges of the patients were examined by both microscopic and small-subunit ribosomal RNA (SSU rRNA) PCR methods. To confirm the species of Lophomonas, two positive samples were sequenced.
In this study, 321 specimens (including 319 BALF and 2 nasal discharges) were microscopically examined. Lophomonas spp. was found in 45(14%) (n = 44 BAL; n = 1 nasal discharge). The mean age of infected patients was 54.9 ± 17.1 years. The following morphological characteristics were observed in both fresh and Papanicolaou-stained smears to identify Lophomonas spp. All microscopically positive specimens were confirmed with genus-specific PCR technique. The obtained sequences were deposited in Gen Bank under the accession numbers (MN243135-36). The BLAST analysis of our two sequences with the only available sequence in the Gen Bank of the Thailand strain of L. blattarum, showed identity of 99-100% and 98.51%, respectively.
To the best of our knowledge, this is the first registry-based study regarding lophomoniasis worldwide. According to our study, the conventional PCR test is an available and reliable tool for confirming the Lophomonas parasite in clinical samples. Moreover, the results confirmed that L. blattarum is circulating at least in our region.
在过去的十年中,已经记录了几例支气管肺滴虫病(BPL)。关于 BPL 患者中滴虫感染的流行病学方面的信息很少。本研究旨在使用形态学和分子检测方法,调查 2017 年至 2019 年期间伊朗滴虫病国家登记中心(INRCL)转诊患者中滴虫属感染的流行率。
我们检查了 2017 年至 2019 年期间在伊朗北部马赞达兰医科大学的 INRCL 登记的患者。所有支气管肺泡灌洗液(BALF)和两名患者的两份鼻分泌物均通过显微镜和小亚基核糖体 RNA(SSU rRNA)PCR 方法进行检查。为了确认滴虫的种属,对两个阳性样本进行了测序。
在这项研究中,共检查了 321 份标本(包括 319 份 BALF 和 2 份鼻分泌物)。在 45(14%)(n=44 BAL;n=1 鼻分泌物)中发现了滴虫属。感染患者的平均年龄为 54.9±17.1 岁。在新鲜和巴氏染色涂片上都观察到以下形态特征来识别滴虫属。所有经显微镜检查阳性的标本均通过属特异性 PCR 技术得到证实。获得的序列已在 Gen Bank 中以 MN243135-36 号提交。我们的两个序列与 Gen Bank 中泰国 L. blattarum 菌株唯一可用序列的 BLAST 分析显示,分别为 99-100%和 98.51%的同一性。
据我们所知,这是全球首例基于登记的滴虫病研究。根据我们的研究,常规 PCR 检测是一种可用于确认临床样本中滴虫寄生虫的可靠工具。此外,结果证实至少在我们的地区存在 L. blattarum。